US drug launch prices reach $257,000 median amid access barriers
A joint ICER and West Health report found that median US net launch prices reached $257,000 in 2025, while only ...
A joint ICER and West Health report found that median US net launch prices reached $257,000 in 2025, while only ...
A systematic review of seven eligible US studies found that Medicare Advantage enrollment was associated with admission to lower-rated nursing ...
A cross-sectional analysis of 4,145 generalist physician groups found that greater multisetting work was associated with lower 2022 Medicare MIPS ...
A firsthand account of Medicare payment reform shows how public inaction can conceal intensive legislative work, persistent budget constraints and ...
A Harvard and Brigham and Women's study of an annual panel-review system shows how academic primary care clinics can transfer ...
A new study finds that the likelihood of primary care follow-up after major surgery varies dramatically between US hospitals, raising ...
A large Medicare analysis finds that heart failure patients who begin cardiac rehabilitation within 180 days of hospital discharge face ...
A large real-world study of Medicare beneficiaries found mepolizumab matched dupilumab for preventing asthma hospitalizations and significantly reduced exacerbation rates, ...
UCSF researchers report in JAMA that four years after the FDA created an over-the-counter hearing aid category, lower prices and ...
A new University of Michigan poll finds that 60 percent of older adults spend less than an hour choosing Medicare ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine